1nrg

Revision as of 19:17, 12 November 2007 by OCA (talk | contribs) (New page: left|200px<br /> <applet load="1nrg" size="450" color="white" frame="true" align="right" spinBox="true" caption="1nrg, resolution 1.95Å" /> '''Structure and Prope...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Structure and Properties of Recombinant Human Pyridoxine-5'-Phosphate Oxidase

File:1nrg.gif


1nrg, resolution 1.95Å

Drag the structure with the mouse to rotate

OverviewOverview

Pyridoxine 5'-phosphate oxidase catalyzes the terminal step in the, synthesis of pyridoxal 5'-phosphate. The cDNA for the human enzyme has, been cloned and expressed in Escherichia coli. The purified human enzyme, is a homodimer that exhibits a low catalytic rate constant of, approximately 0.2 sec(-1) and K(m) values in the low micromolar range for, both pyridoxine 5'phosphate and pyridoxamine 5'-phosphate. Pyridoxal, 5'-phosphate is an effective product inhibitor. The three-dimensional fold, of the human enzyme is very similar to those of the E. coli and yeast, enzymes. The human and E. coli enzymes share 39% sequence identity, but, the binding sites for the tightly bound FMN and substrate are highly, conserved. As observed with the E. coli enzyme, the human enzyme binds one, molecule of pyridoxal 5'-phosphate tightly on each subunit.

DiseaseDisease

Known disease associated with this structure: Pyridoxamine 5 -phosphate oxidase deficiency OMIM:[603287]

About this StructureAbout this Structure

1NRG is a Single protein structure of sequence from Homo sapiens with PO4, FMN, PLP and BME as ligands. Full crystallographic information is available from OCA.

ReferenceReference

Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase., Musayev FN, Di Salvo ML, Ko TP, Schirch V, Safo MK, Protein Sci. 2003 Jul;12(7):1455-63. PMID:12824491

Page seeded by OCA on Mon Nov 12 18:24:24 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA